Successful treatment of first and second recurrence of acute lymphoblastic leukemia after related allogeneic bone marrow transplant at unusual sites using single-dose vincristine followed by interferon-α2b and granulocyte-macrophage colony-stimulating factor

Leuk Lymphoma. 2013 May;54(5):1107-9. doi: 10.3109/10428194.2012.734617. Epub 2012 Oct 16.

Authors

Leonid Volodin, Prakash Peddi, Amol Takalkar, Jill M Comeau, Jaime L Shahan, Gerhard C Hildebrandt

PMID: 23020692
DOI: 10.3109/10428194.2012.734617

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Bone Marrow Transplantation
Female
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Interferon-alpha / administration & dosage
Interferon-alpha / therapeutic use*
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
Recurrence
Transplantation, Homologous
Treatment Outcome
Vincristine / administration & dosage
Vincristine / therapeutic use*

Substances

Interferon-alpha
Vincristine
Granulocyte-Macrophage Colony-Stimulating Factor